ACHIEVE LIFE SCIENCES, INC. - ACHV
Ownership (Schedule 13D / 13G) · latest 50 filings
· Back to all files
Visible: 0
| Filed | Form | Reporting person | Percent | Shares | SEC |
|---|---|---|---|---|---|
| Apr 27, 2026 | SCHEDULE 13D | — | 4.99% | 1,700 | View |
| Apr 24, 2026 | SCHEDULE 13G | Paradigm BioCapital Advisors LP | 9.2% | 9,903,712 | View |
| Apr 24, 2026 | SCHEDULE 13G | Paradigm BioCapital Advisors GP LLC | 9.2% | 9,903,712 | View |
| Apr 24, 2026 | SCHEDULE 13G | Senai Asefaw, M.D. | 9.2% | 9,903,712 | View |
| Apr 24, 2026 | SCHEDULE 13G | Paradigm BioCapital International Fund Ltd. | 8.1% | 8,687,536 | View |
| Apr 24, 2026 | SCHEDULE 13D | — | 100.0% | — | View |
| Apr 24, 2026 | SCHEDULE 13G | Frazier Life Sciences Public Fund, L.P. | 6.5% | 6,625,788 | View |
| Apr 24, 2026 | SCHEDULE 13G | FHMLSP, L.P. | 6.5% | 6,625,788 | View |
| Apr 24, 2026 | SCHEDULE 13G | FHMLSP, L.L.C. | 6.5% | 6,625,788 | View |
| Apr 24, 2026 | SCHEDULE 13G | Frazier Life Sciences XI, L.P. | 0.1% | 61,958 | View |
| Apr 24, 2026 | SCHEDULE 13G | FHMLS XI, L.P. | 0.1% | 61,958 | View |
| Apr 24, 2026 | SCHEDULE 13G | FHMLS XI, L.L.C. | 0.1% | 61,958 | View |
| Apr 24, 2026 | SCHEDULE 13G | Frazier Life Sciences XII, L.P. | 0.8% | 777,090 | View |
| Apr 24, 2026 | SCHEDULE 13G | FHMLS XII, L.P. | 0.8% | 777,090 | View |
| Apr 24, 2026 | SCHEDULE 13G | FHMLS XII, L.L.C. | 0.8% | 777,090 | View |
| Apr 24, 2026 | SCHEDULE 13G | Venrock Healthcare Capital Partners III, L.P. | 5.2% | 5,502,064 | View |
| Apr 24, 2026 | SCHEDULE 13G | VHCP Co-Investment Holdings III, LLC | 5.2% | 5,502,064 | View |
| Apr 24, 2026 | SCHEDULE 13G | Venrock Healthcare Capital Partners EG, L.P. | 5.2% | 5,502,064 | View |
| Apr 24, 2026 | SCHEDULE 13G | VHCP Management III, LLC | 5.2% | 5,502,064 | View |
| Apr 24, 2026 | SCHEDULE 13G | VHCP Management EG, LLC | 5.2% | 5,502,064 | View |
| Apr 24, 2026 | SCHEDULE 13G | Nimish Shah | 5.2% | 5,502,064 | View |
| Apr 24, 2026 | SCHEDULE 13G | Bong Y. Koh | 5.2% | 5,502,064 | View |
Percent = "% of class represented by amount beneficially owned" for this reporting person in the filed 13D/13G.
Shares = reported beneficial ownership amount for the same row (not portfolio shares from 13F).
Amendments (/A) can repeat the same holder over time, so rows should not be summed.
Extraction is best-effort from filing text and can be missing or noisy; verify exact figures via the SEC link in each row.